TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - ATYR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - ATYR

Rosen Law Firm is pursuing a securities class action against aTyr Pharma for allegedly providing false and misleading statements about the efficacy of their drug Efzofitimod during the period of January 16, 2025 to September 12, 2025.

Insights
BAM   positive

Partnering in an $80 billion nuclear reactor development project indicates strategic growth opportunity


ATYR   negative

The lawsuit alleges the company disseminated false statements about their drug's capabilities, potentially misleading investors and causing financial damages